Log in to search using one of your social media accounts:

 

Medical News Today: Could a protein from intestinal worms lead to a cure for asthma?
A new study shows that HpARI, a protein made by intestinal worms, could lead to treatments that reduce and prevent asthma and other allergic responses. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 18, 2017 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Postdoctoral Research Associate, Fungal Redox Mechanisms and Biomedical Pathogenesis - USA
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 18, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Killer Fungus to take over Manchester Science Festival
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 17, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Preventing the spread of fungal disease between ʻōhiʻa trees in Hawaiʻi
Tue, 10/17/2017 - 10:41News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 17, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Kneeling Posture Impacts Chest Compressions ’ Effectiveness
Efficacy of CPR compressions better in self - adjusted, nearest kneeling postures versus farthest (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 17, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pulmonology, Journal, Source Type: news

Dark Skies and Chest Pain as California Fires Spew Smoke 100 Miles Dark Skies and Chest Pain as California Fires Spew Smoke 100 Miles
California's deadly wildfires have darkened the skies for a hundred miles, causing respiratory problems and making it hard to see the sun not only in the state's wine country but as far as San Francisco and Sacramento.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 16, 2017 Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news

ResMed claims wins, updates on continuing patent war with Fisher & Paykel
ResMed (NYSE:RMD) this month updated on a number of global patent infringement suits in the UK, Australia and New Zealand as it continues to battle with Fisher & Paykel Healthcare (NZE:FPH). The San Diego, Calif.-based company said that it has decided to proceed with the defense of 1 of 3 UK ResMed patents that were challenged by Fisher & Paykel while agreeing to revoke the other 2 patents. ResMed said that the revoked patent will “have no commercial impact on sales of ResMed’s products” and that it’s not binding on the European Patent Office or the German Courts. In Australia, Res...
Source: Mass Device - October 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Legal News Patent Infringement Respiratory Fisher & Paykel Healthcare ResMed Inc. Source Type: news

WHO to establish high-level commission on noncommunicable diseases
The commission's aim is to identify innovative ways to curb the world's biggest causes of death and extend life expectancy for millions of people. The commission will support ongoing political efforts to accelerate action on cardiovascular disease, cancers, diabetes and respiratory disease, as well as reducing suffering from mental health issues and the impacts of violence and injuries. (Source: PHPartners.org)
Source: PHPartners.org - October 16, 2017 Category: International Medicine & Public Health Source Type: news

Chronic Pulmonary Aspergillosis IV
Monday, October 16, 2017 - 08:36Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 16, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Chronic Pulmonary Aspergillosis III
Monday, October 16, 2017 - 08:35Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 16, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Chronic Pulmonary Aspergillosis II
Monday, October 16, 2017 - 08:34Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 16, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Chronic Pulmonary Aspergillosis I
Monday, October 16, 2017 - 08:32Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 16, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Current Medical Therapy for Sarcoidosis Current Medical Therapy for Sarcoidosis
What do we currently know about the indications for treatment and the efficacy of therapeutic options for sarcoidosis?Seminars in Respiratory and Critical Care Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Endogenous infection marker guides antibiotic therapy
(University of Basel) The endogenous infection marker procalcitonin can help to guide the use of antibiotics when treating infections. The course of antibiotic therapy is shortened, and its side effects and mortality rate also decrease, as researchers from the University of Basel and other colleagues report in the journal The Lancet Infectious Diseases. They conducted a meta-analysis of over 6,700 international data sets from patients with respiratory infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 16, 2017 Category: Infectious Diseases Source Type: news

What Are the Health Needs of Incarcerated Youth?
Discussion In the US during 2011, ~60,000 youth were incarcerated at some time in a correctional facility. Boys are detained more than girls (86% vs 14% respectively in the US, 95% male in the United Kingdom in 2014) but girls have more health issues. There are racial and ethnic differences with 38-40% of detainees being black, 23% being Hispanic/Latino and 32% being white, and 5% other. For detained youth, 5% are for violent crimes, 22% for non-violent property crimes and the majority of the rest are for non-violent offices such as substance use. The average length of detainment is 3-4 months and unfortunately the rates o...
Source: PediatricEducation.org - October 16, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Procalcitonin-Guided Antibiotic Therapy Tied to Improved Survival in Acute Respiratory Infection (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH For patients with acute respiratory tract infection, using procalcitonin levels to guide treatment decisions can reduce antibiotic use and improve survival, finds a meta-analysis in the Lancet Infectious Diseases. High procalcitonin levels can … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 16, 2017 Category: Primary Care Source Type: news

Particle Pollution and Your Patients' Health: Evidence-Based Training for Healthcare Professionals
U.S. Environmental Protection Agency. 08/21/2017 This course explains particle pollution, also known as particulate matter or PM, which is the main component of haze, smoke, and dust. It explains what size particles are the greatest health concern, and where and when they are a problem. It identifies how particle pollution exposure affects the cardiovascular and respiratory systems, the general population, and patients with cardiovascular or respiratory disease. It explains the purpose and use of the Air Quality Index for advising patients how to protect their health. (Text) (Source: Disaster Lit: Resource Guide for Disast...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - October 14, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

ZOLL Showcases New Ventilator Capabilities at AMTC 2017
CHELMSFORD, MASS.—ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, will offer Air Medical Transport Conference 2017  (AMTC) attendees the opportunity to experience the new capabilities of its mechanical ventilation devices in booth 901 October 16-18 at the Fort Worth Convention Center in Fort Worth, Texas. Respiratory Care—Launching New Capabilities Using ZOLL’s EMV+ Ventilator, participants will experience firsthand how lungs adapt to each ventilator mode. With its unique Smart HelpT technology, ZOLL ventilators provid...
Source: JEMS Patient Care - October 13, 2017 Category: Emergency Medicine Authors: ZOLL Tags: Airway & Respiratory Cardiac Resuscitation Equipment Gear Operations Source Type: news

ZOLL Showcases New Ventilator Capabilities at AMTC 2017
CHELMSFORD, MASS.—ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, will offer Air Medical Transport Conference 2017  (AMTC) attendees the opportunity to experience the new capabilities of its mechanical ventilation devices in booth 901 October 16-18 at the Fort Worth Convention Center in Fort Worth, Texas. Respiratory Care—Launching New Capabilities Using ZOLL’s EMV+ Ventilator, participants will experience firsthand how lungs adapt to each ventilator mode. With its unique Smart HelpT technology, ZOLL ventilators provid...
Source: JEMS Operations - October 13, 2017 Category: Emergency Medicine Authors: ZOLL Tags: Airway & Respiratory Cardiac Resuscitation Equipment Gear Operations Source Type: news

Propeller Health launches API to provide local asthma conditions to orgs, patients
Earlier this week, Propeller Health released an application programming interface to give local asthma conditions to anyone within the U.S. who is interested in using that data. The Air by Propeller API is a free service that uses a machine-learning model based on millions of days of anonymous asthma symptom data and environmental data. The model uses that information to predict potential effects on people’s breathing. Get the full story at our sister site, Drug Delivery Business News. The post Propeller Health launches API to provide local asthma conditions to orgs, patients appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - October 13, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Big Data Health Information Technology Pharmaceuticals Respiratory Propeller Health Source Type: news

ResMed touts win in German patent spat with Fisher & Paykel
ResMed (NYSE:RMD) this week touted a win in a patent spat with Fisher & Paykel Healthcare (NZE:FPH) after a German court determined that its AirSense 10, AirCurve 10 and Lumis devices and included humidifiers do not infringe on a Fisher & Paykel patent. The decision was made by the Munich District Court, the San Diego, Calif.-based company said. ResMed added that although its patents were found to not infringe on the German utility model patent, it will continue to challenge the validity of the patent with the German Patent and Trademark Office. “We applaud the German court for its sensible app...
Source: Mass Device - October 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Legal News Patent Infringement Respiratory Fisher & Paykel Healthcare ResMed Inc. Source Type: news

Guidelines Needed for 6MWT in Idiopathic Pulmonary Fibrosis
No specific guidelines for use of six - minute walk test in growing population with IPF (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 13, 2017 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Nursing, Pulmonology, Geriatrics, Journal, Source Type: news

Goldilocks and the three azoles
Friday, October 13, 2017 - 15:56Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Resistance epidemiology
Friday, October 13, 2017 - 15:54Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

News from the lab
Friday, October 13, 2017 - 15:51Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

New categories of hematological malignancies at risk for invasive fungal infections
Friday, October 13, 2017 - 15:46Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Local penny-stock biotech firm lays off 71% of employees
A Holliston-based biotech company that ’s been developing organ implants to treat cancers in the respiratory tract is laying off 71 percent of its workforce, or 17 employees, after an investor reversed course on plans to buy $3.1 million worth of shares of the company in a private placement. Biostage Inc. (OTC: BSTG) announced the sta ff cuts late Thursday, less than a week after being delisted from the Nasdaq exchange for having too low a stock price. The company’s shares haven’t closed above… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 13, 2017 Category: Pharmaceuticals Authors: Don Seiffert Source Type: news

Medical News Today: Childhood respiratory infections linked with celiac disease
New research concludes that respiratory infections in at-risk children may significantly increase the likelihood of developing celiac disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 13, 2017 Category: Consumer Health News Tags: Pediatrics / Children's Health Source Type: news

New Preparation of Itraconazole (Pulmazole) Gets FDA Approval
Fri, 10/13/2017 - 09:59News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Voriconazole
Friday, October 13, 2017 - 09:48Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Isavuconazole
Friday, October 13, 2017 - 09:46Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

VL-2397 (Vical)
Friday, October 13, 2017 - 09:44Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

CD101 (Cidara)
Friday, October 13, 2017 - 09:42Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

APX001 (Amplyx)
Friday, October 13, 2017 - 09:41Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Galactomannan
Friday, October 13, 2017 - 09:37Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Mechanism of multidrug resistance
Friday, October 13, 2017 - 09:36Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

MALDI identification and more of mould
Friday, October 13, 2017 - 09:30Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Global burden of fungal infections
Friday, October 13, 2017 - 09:24Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Trump Signs Executive Order to Allow Cheaper Health Plans Trump Signs Executive Order to Allow Cheaper Health Plans
The executive order would lift restrictions on association health plans, letting them sell less expensive, skimpier plans; short-term insurance plans, lasting for up to a year, could be sold.Medscape Medical News (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - October 12, 2017 Category: Respiratory Medicine Tags: Family Medicine/Primary Care News Alert Source Type: news

2004 to 2014 Saw Increases in Risk Factors in Ischemic Stroke
Increases in prevalence of hypertension, diabetes, dyslipidemia, smoking, and drug abuse in AIS (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 12, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Emergency Medicine, Neurology, Nursing, Pathology, Pulmonology, Journal, Source Type: news

Six - Month Tai Chi Program Improves Physical Activity in CHD
Improvements in activity, weight, QoL for patients with coronary heart disease refusing cardiac rehab (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 12, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Pulmonology, Surgery, Journal, Source Type: news

Boehringer Ingelheim, Anthem partner for largest real-world COPD trial
As part of a research collaboration launched in 2014, Boehringer Ingelheim and Anthem have partnered to study people with chronic obstructive pulmonary disease in real-world settings to assess how commonly-prescribed drugs may reduce the occurrence of COPD exacerbations. The team, which also includes Anthem’s outcomes research subsidiary HealthCore, plans to investigate whether adding an inhaled corticosteroid to a LAMA-LABA combination provides a meaningful benefit – a question under debate in the respiratory space. Get the full story at our sister site, Drug Delivery Business News. The post Boehring...
Source: Mass Device - October 12, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Anthem Inc. Boehringer Ingelheim Pharmaceuticals Source Type: news

MRC Centre for Medical Mycology Scholarships
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 12, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Website terms and conditions
Before becoming a member of the Aspergillus Website you must read ourTerms and ConditionsPost date: 12 Oct 2017 - 1:39pm (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 12, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Terms and conditions of use
Terms and ConditionsWebsite terms and conditions(1)         IntroductionThese terms and conditions govern your use of our website; by using our website, you accept these terms and conditions in full. If you disagree with any part of these terms and conditions, do not use our website.(2)         Intellectual property rightsPost date: 12 Oct 2017 - 8:47am (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 12, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

'Heat-Not-Burn Cigarettes' Aiming for U.S. Market
Title: 'Heat-Not-Burn Cigarettes' Aiming for U.S. MarketCategory: Health NewsCreated: 10/11/2017 12:00:00 AMLast Editorial Review: 10/12/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - October 12, 2017 Category: Respiratory Medicine Source Type: news

More Hardcore Smokers Trying to Kick the Habit
Title: More Hardcore Smokers Trying to Kick the HabitCategory: Health NewsCreated: 10/11/2017 12:00:00 AMLast Editorial Review: 10/12/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - October 12, 2017 Category: Respiratory Medicine Source Type: news

SGS and Bavarian Nordic developing challenge strain to combat respiratory virus ​
ZURICH (Reuters) - SGS and Bavarian Nordic are teaming up to develop a virus challenge strain to combat a common respiratory illness. (Source: Reuters: Health)
Source: Reuters: Health - October 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news